Skip to main content
. Author manuscript; available in PMC: 2019 Apr 4.
Published in final edited form as: Ann Intern Med. 2018 May 1;168(11):757–765. doi: 10.7326/M17-3008

Appendix Table 2.

Mammography Sensitivity by Clinical and Automated BI-RADS Breast Density, by Timing of Density Measure Before Cancer Diagnosis, Among Women With Mammograms in Both Time Periods

Variable Almost
Entirely
Fatty
Scattered
Fibroglandular
Densities
Heterogeneously
Dense
Extremely
Dense
Overall

Recent breast density measure*
 Clinical BI-RADS density
  Interval cancer cases    5   27   60 26 118
  Screen-detected cancer cases   54 244 190 40 528
  Sensitivity (95% CI), % 92 (84–99) 90(86–94) 76(71–81) 61 (49–72) 82 (79–85)
 Automated BI-RADS density
  Interval cancer cases    8   23   48 39 118
  Screen-detected cancer cases 131 191 153 53 528
  Sensitivity (95% CI), % 94 (90–98) 89 (85–93) 76 (70–82) 58 (48–68) 82 (79–85)
Distant breast density measure
 Clinical BI-RADS density
  Interval cancer cases    4   23   62 29 118
  Screen-detected cancer cases   65 225 188 50 528
  Sensitivity (95% CI), % 94(89–100) 91 (87–94) 75(70–81) 63 (53–74) 82 (79–85)
 Automated BI-RADS density
  Interval cancer cases    6   26   39 47 118
  Screen-detected cancer cases 118 192 151 67 528
  Sensitivity (95% CI), % 95 (91–99) 88 (84–92) 79 (74–85) 59 (50–68) 82 (79–85)

BI-RADS = Breast Imaging Reporting and Data System.

*

Defined as >6 mo to <2 y before cancer diagnosis.

Measured with Volpara software.

Defined as 2–5 y before cancer diagnosis.